Medical Affairs Analytics & KOL Intelligence
Move medical affairs from activity reporting to scientific intelligence – with AI-powered KOL identification, MSL enablement, and content intelligence.
40%
Increase in user adoption for 70+ MSLs via unified disease-area intelligence
85%+
Accuracy and $170K savings via ML-powered KOL segmentation across 23 countries
3X Faster
Scientific trend identification via AI-NLP content intelligence
The Problem Medical Affairs Leaders Face
Medical affairs is one of the least analytically mature functions in pharma. While commercial teams have invested heavily in CRM analytics and field optimization, medical affairs often relies on basic activity reports and manual literature review.
Most organizations can tell you how many HCP interactions their MSLs had last quarter. What they cannot tell you is which scientific themes are emerging, which KOLs are shifting research focus, or how MSL engagement influences downstream prescribing. The insights are trapped in free-text notes, disconnected CRM records, and individual memories.
What We Do
We empower medical affairs teams with AI-driven platforms that unify intelligence, automate KOL identification, and accelerate scientific insights for measurable impact.
Unified Medical Affairs Intelligence Platform
We consolidate medical affairs data from 30+ fragmented sources into a unified platform on Snowflake. Role-based dashboards with disease-area selectors give MSLs and medical directors instant access to engagement metrics, scientific trends, and competitive landscape – across all therapeutic areas.
AI-Powered KOL Identification & Segmentation
Machine learning models analyze publication networks, collaboration patterns, prescribing influence, congress activity, and social media presence to identify and segment KOLs. The models continuously refresh and achieve 85%+ accuracy – far surpassing legacy business rules.
Scientific Content Intelligence
AI-NLP tools automatically scan publications, conference abstracts, and regulatory filings to identify emerging scientific themes, competitive data readouts, and label expansion opportunities. This surfaces insights that would take weeks of manual review.
Medical Engagement Analytics
We connect medical affairs engagement data with commercial outcomes, revealing how MSL interaction with KOLs influences prescribing patterns in surrounding geographies – one of the most valuable cross-functional insights in pharma.
Who It’s For
Designed for medical affairs leaders, MSL teams, and analytics functions driving data‑driven KOL engagement and scientific impact.
Results
40%
User adoption increase, 70+ MSLs enabled, 30+ sources consolidated (Snowflake, dbt, Fivetran, Power BI)
85%+
Accuracy, $170K savings, 23 countries automated for KOL segmentation (Dataiku, Python, ML)
$200K
Savings, 3× faster insights via AI-NLP drug experience analysis (Dataiku, NLP, Python)
Resources
Explore how leading life sciences organizations are transforming medical affairs with AI-driven insights. From modernizing data platforms to enabling precise KOL engagement, these resources highlight practical strategies and proven outcomes that accelerate scientific intelligence and improve decision-making.
Blog
The Data Platform Modernization Playbook for Life Sciences: Cloud, Governance, and AI Readiness
Read MoreFAQs
What is the difference between KOL identification and KOL management?
KOL identification is the process of determining which healthcare professionals have the most scientific influence in a given therapeutic area. KOL management is the ongoing relationship strategy. We focus on identification and segmentation using AI, providing the intelligence foundation for your management programs.
How does ML-based KOL identification work?
Machine learning models analyze publication networks, collaboration patterns, prescribing data, congress activity, and referral patterns to identify influence – not just publication volume. This reveals emerging KOLs that business rules miss.
Can this platform cover multiple therapeutic areas?
Yes. Our platform uses disease-area selectors that allow MSLs and medical directors to switch between therapeutic areas while accessing the same data infrastructure and governance framework.
How do you measure medical affairs impact on commercial outcomes?
We link medical engagement data with commercial analytics to analyze correlations between MSL interactions with KOLs and prescribing patterns in surrounding geographies. This provides evidence-based measurement of medical affairs value.
Request a Medical Affairs Intelligence Assessment
Infocepts
